
ARGX vs MRNA
$ARGX vs $MRNA head to head: price, market cap, valuation, dividend, free float, relative volume and how actively each trades. The bigger value in the size rows is bolded. Tap either ticker for its live chart, full ownership breakdown and real-time alerts.
ARGX vs MRNA: trend, levels and the market
One year to 2026-11-18, against the S&P 500 (+10.6%). Split-adjusted daily closes.
- ·ARGX has the cleaner trend, above both its 50- and 200-day averages, where MRNA is above one and below the other.
- ·Only MRNA beat the market over the past year, by 679.1%, while ARGX trailed the S&P 500 at +10.6% by 8.1%.
- ·The last month has flipped the order: ARGX leads over the month (+8.2% against -18.7%) even though MRNA leads over the year.
- ·ARGX sits closer to its support, 0.4% above it at $937.26, while MRNA is 6.5% above its own at $179.56.
Support and resistance are daily prices the stock has turned at three or more times, within 35% of the price. The loading zone is the nearby price where the heaviest volume traded. These describe where a stock has been, not where it will go. Not investment advice.
ARGX vs MRNA: the quick read
- ·MRNA is the larger company by market cap ($83.68B vs $59.59B).
- ·MRNA has been more active on our scanner (341 vs 89 alerts in 30 days).
- ·ARGX has the smaller float (62.9M vs 360.3M), which tends to mean sharper, more volatile moves.
- ·These sit in different industries (Biological Products, (No Diagnostic Substances) vs BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)), so they answer to different catalysts and a move in one says little about the other.
- ·MRNA trades at a small fraction of the other's share price, so position sizing and the size of a "normal" move differ a lot between them.
- ·MRNA draws far more of our scanner's attention, 341 unusual-volume alerts in 30 days against 89, so it is the more actively traded of the two by some distance.
- ·They are closely matched in size, within 40% of each other on market cap, which makes the rest of this table the interesting part.
- ·They are pulling apart today: ARGX is outperforming the other by roughly 6.5 percentage points on the session.
Objective differences only. Not investment advice.
Watching ARGX or MRNA? Get each morning’s movers by email
Free daily email of the top plays and unusual-volume alerts our scanner flags. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Frequently asked questions
Everything you need to know comparing ARGX and MRNA on TheDesperateTrader.
- Is ARGX or MRNA the better stock?
- "Better" depends on your goal, and these two are not alike. MRNA is the larger company by market cap ($83.68B vs $59.59B). MRNA has been more active on our scanner (341 vs 89 alerts in 30 days). ARGX has the smaller float (62.9M vs 360.3M), which tends to mean sharper, more volatile moves. Those are the measured differences, not a recommendation, and nothing here is investment advice.
- What is the difference between ARGX and MRNA?
- The differences that matter: they are not in the same business - ARGX is biological products, (no diagnostic substances) and MRNA is biological products, (no diagnostic substances); they are similar in size ($59.59B vs $83.68B); they trade at very different share prices ($941.25 vs $192.03); ARGX sits at 68% of its 52-week range against 66% for MRNA; our scanner flagged ARGX 89 times in the last 30 days against 341 for MRNA. Everything above is measured from the latest completed session and SEC filings.
- Which of ARGX and MRNA is more active right now?
- Right now ARGX is at about 0.9x its normal volume and MRNA is at about 0.5x, so ARGX is the one drawing unusual attention today. Relative volume (RVOL) compares a stock's volume to its own recent average, so it reads the same way for a megacap and a microcap and is the quickest way to tell which of two similar names is actually in play.
- Is ARGX or MRNA in the stronger trend?
- ARGX is above its 50-day average of $919.83 and above its 200-day average of $861.84; MRNA is below its 50-day average of $205.61 and above its 200-day average of $98.86. MRNA leads 3 of the 5 measures on this page (1 year, vs S&P 500, 3 months, 1 month, trend). A trend is where a stock has been, not a forecast, and nothing here is investment advice.
- Is this comparison data live?
- Prices and % changes are anchored to the latest completed session and split-adjusted, so a reverse split never shows as a fake move. Float is estimated from SEC filings and refreshed as new filings publish.
Trading ARGX or MRNA? Get real-time unusual-volume alerts the moment either one moves, free.
No card · 5 premium daysMore ARGX and MRNA comparisons
Same sector, similar size. These are the peers each one is usually weighed against.
Explore the market
Free, live market tools. No account required to look.